Could GLP-1 drugs help women with PCOS beyond weight loss?
A scoping review of 28 studies suggests that GLP-1 receptor agonists may improve androgen levels and menstrual function in women with polycystic ovary syndrome (PCOS), alongside their established metabolic benefits. Evidence for improved ovulation, fertility, and pregnancy outcomes remains limited, and the researchers could not determine whether reproductive benefits result directly from the…
Read original article on The Medical News →Related news
-
Menopause reshapes women's careers, from brain fog to changing priorities
United Kingdom
-
Single blood protein stands out among 30 tests for assessing fatty liver disease
United Kingdom
-
Why you still want dessert even when you're completely full
United Kingdom
-
The type of fiber you eat shapes how gut bacteria feed and work together
United Kingdom
-
Eating walnuts was linked to higher IgG levels, but what does that mean for health?
United Kingdom
-
Housing Nonprofit Funds $16.5 Million in Eviction Relief to Assist Renters
United Kingdom
-
Extreme heat and cold hit some people far harder, and it's not just about illness
United Kingdom
-
Tumor index can identify breast cancer patients' drug response
United Kingdom